↵
Product Introduction
Name:GDF-8
Product Benefits:Inhibit muscle proliferation and differentiation
CAS:60580-62-7
Capacity:1mg/vial
Product Form:White or off-white powder(Peptides)
Shelf Life:2-3Years(The product packaging date shall prevail)
GDF-8 related information
GDF-8 (Growth Differentiation Factor 8) is a protein belonging to the transforming growth factor β (TGF-β) superfamily. It is widely present in various tissues of mammals, especially in muscle tissue. It plays a key role in muscle development, cell proliferation and differentiation, and the regulation of muscle size. GDF-8 is best known for its role as an inhibitor of muscle growth, which has an important influence on the regulation of muscle mass and size.
Physical and chemical properties
GDF-8 is a precursor protein composed of approximately 375 amino acids. The mature form usually consists of two identical subunits, which are connected by disulfide bonds. Its molecular weight is approximately between 38-45 kDa. As a member of the TGF-β superfamily, GDF-8 has similar structural characteristics to other family members, including a dimer structure at the C-terminus.
GDF-8 acts through signal transduction pathways, especially through signal pathways mediated by SMAD proteins. Its main function is to inhibit muscle growth and regulate the proliferation and differentiation of muscle cells.
Main functions
1. **Inhibit muscle growth**:
- As an inhibitor of muscle growth, GDF-8 can inhibit the activation and proliferation of muscle stem cells (satellite cells) and limit the increase in muscle volume. It participates in the regulation of muscle mass under normal physiological conditions and prevents excessive muscle growth.
- In some animal models, the knockout or inhibition of GDF-8 leads to a significant increase in muscle volume, which is particularly evident in transgenic animals (such as "super cows").
2. Regulate bone and fat metabolism:
- In addition to its role in muscle, GDF-8 also has a certain regulatory role in bone and fat metabolism. It indirectly regulates the body's overall metabolism and growth by affecting the cell differentiation of these tissues.
3. Inhibit stem cell proliferation and differentiation:
- GDF-8 can also inhibit the proliferation of stem cells through the SMAD signaling pathway and regulate their differentiation process, thereby affecting tissue repair and regeneration.
4. Promote muscle aging:
- With the increase of age, the expression level of GDF-8 increases, which may be related to muscle atrophy (muscle aging) during aging.
### Dosage and Use
In medicine and research, the use of GDF-8 is usually limited to basic research and the exploration of specific diseases or symptoms. Its dosage is mainly set according to the purpose of the experiment and is usually calculated in micrograms (mcg).
Clinical application research:
- **Gene therapy and drug development**: Inhibitors targeting GDF-8 are being studied, especially in the treatment of muscular dystrophy (such as muscular dystrophy), aging, or other muscle-related diseases. If the expression of GDF-8 can be regulated or inhibited, it is expected to promote muscle regeneration and growth.
- **Muscle disease**: For example, for muscular dystrophy and muscle recovery after spinal cord injury, GDF-8 inhibitors may be an effective treatment.
Half-life and pharmacokinetics
The metabolic characteristics of GDF-8 in the body have not been clearly and extensively studied. Usually, the half-life is affected by multiple factors (such as dosage, route of administration, individual differences, etc.). As a protein, it has poor stability in the body and usually requires local injection or gene therapy to work effectively. Its half-life is usually short, and its effects that last longer in the body may be achieved through sustained local delivery or gene editing technology.
Cycle and Effects
- **Muscle Growth and Repair Cycle**: GDF-8 usually plays a regulatory role in the normal development of muscles, inhibiting excessive muscle hyperplasia. By inhibiting the activation of satellite cells, GDF-8 helps maintain the proper size of muscles.
- **Muscle Decline and Regeneration**: In the context of aging and muscle damage, the expression of GDF-8 increases, and this effect may be related to aging-related muscle atrophy. Inhibiting the expression of GDF-8 may help improve the loss of muscle mass caused by aging.
- **Affecting Muscle Recovery**: After muscle injury or strenuous exercise, the level of GDF-8 may change, and its regulatory effect on satellite cells affects the muscle repair process.
Clinical and Research Applications
1. **Gene Knockout or Antibody Inhibition**: Through gene knockout or antibody neutralization of GDF-8 activity, experimental animals (such as mice, pigs, and cattle) often show a significant increase in muscle mass, showing its inhibitory effect on muscle growth. This effect suggests a key role for GDF-8 in controlling muscle volume.
2. **Treatment of muscle-related diseases**: For patients with muscular dystrophy (e.g., Duchenne muscular dystrophy), inhibition of GDF-8 may help promote muscle regeneration and repair.
3. **Sports medicine**: Athletes and some fitness enthusiasts may also be interested in increasing muscle mass by regulating GDF-8, but this practice is challenged by ethical and health risks.
Risks and side effects
- **Overgrowth**: Although inhibition of GDF-8 may have a positive effect on muscle growth, it may also lead to uncontrolled tissue proliferation and increase the risk of tumors.
- **Unbalanced metabolism**: GDF-8 not only regulates muscle, but also plays a role in bone and fat metabolism, and changes in its expression may affect systemic metabolic balance.
- **Immune response**: When intervening with GDF-8 through antibodies or gene therapy, immune responses may be triggered, resulting in reduced therapeutic efficacy or side effects.
Summary
GDF-8 is a key biological molecule that regulates muscle development and maintenance primarily by inhibiting muscle growth. It has potential applications in many biomedical fields, including aging, muscular dystrophy, and gene therapy. Although it has great promise in basic research and potential treatment, its clinical application still needs further research and exploration to ensure safety and effectiveness.

GDF-8 Applicable Population Working Principle
GDF-8 (also known as myostatin 8 or skeletal muscle growth inhibitor) is a protein produced by muscle that plays an important role in regulating muscle growth and development. GDF-8 is a member of the transforming growth factor-β (TGF-β) family, which controls muscle growth by inhibiting the proliferation and differentiation of muscle cells. Its research focuses on the treatment of muscle hypertrophy, muscle atrophy, and related diseases.
How GDF-8 works
The mechanism of action of GDF-8 is mainly through binding to its receptor, initiating a series of cell signaling pathways, and ultimately inhibiting the proliferation and differentiation of muscle cells. Studies have shown that GDF-8 has the following important functions:
1. **Inhibit muscle growth**: GDF-8 limits the expansion and proliferation of muscle fibers and avoids excessive muscle growth.
2. **Regulate muscle regeneration**: GDF-8 participates in the repair process after muscle damage by inhibiting the activity of muscle stem cells.
3. **Hypertrophy and atrophy of skeletal muscle**: GDF-8 is also related to muscle hypertrophy and atrophy, especially under certain metabolic diseases, malnutrition, and deterioration of motor ability.
Applicable population
GDF-8 is mainly used to study and treat the following populations:
- **Muscle atrophy patients**: such as muscle atrophy caused by age, disease (such as muscular dystrophy, cancer, long-term bed rest), etc.
- **Athletes or fitness enthusiasts**: GDF-8 is an inhibitor of muscle growth. Some studies have tried to promote muscle growth by inhibiting its activity, especially in terms of increasing muscle strength and volume.
- **Elderly people**: As we age, muscles gradually atrophy. Inhibiting the effects of GDF-8 may help delay or improve muscle health.
Usage and Dosage
GDF-8 itself is not a conventional drug. It has not been widely used clinically. It is mainly understood through research and clinical trials. In some experimental applications, drugs that inhibit GDF-8 may be used as a potential treatment.
1. **Inhibitor application**: Scientists have developed some drugs that can inhibit the activity of GDF-8 (such as anti-GDF-8 antibodies). The dosage and use of these drugs are usually specifically adjusted in clinical trials.
2. **Gene therapy**: Some studies have attempted to inhibit the expression of the GDF-8 gene through gene editing technology (such as CRISPR/Cas9) to promote muscle growth.
Currently, the application of GDF-8 is mostly concentrated in laboratory research and animal experiments, and it has not been widely approved as a routine treatment. Future clinical studies may provide more information on how to safely and effectively use this mechanism.
Other related issues
- **Side effects**: Although inhibiting GDF-8 can promote muscle growth, long-term inhibition of its function may bring potential side effects, such as excessive muscle hyperplasia and metabolic disorders in the body. Therefore, caution is required when using it clinically.
- **Future direction**: Scientists are exploring how to treat muscle-related diseases such as muscular dystrophy and osteoporosis by precisely regulating the activity of GDF-8.

Benefits of GDF-8
GDF-8 (Growth Differentiation Factor 8) is a protein belonging to the TGF-β (Transforming Growth Factor-β) superfamily. GDF-8 is mainly expressed in muscle, and its main function is to regulate muscle growth, especially to limit excessive muscle growth. Although GDF-8 has an inhibitory effect on muscle, recent studies have found that it plays an important role in a variety of biological processes and has some potential benefits. Below we will explore the role of GDF-8 and its potential benefits in detail.
1. The role of GDF-8 in muscle growth
GDF-8 is a key regulator of muscle development and growth. Its main function is to limit excessive muscle growth by inhibiting the proliferation and differentiation of muscle cells. Specifically, GDF-8 interacts with other myogenesis-related factors (such as IGF-1) to regulate muscle mass and volume.
- **Inhibit muscle hyperplasia and differentiation**: GDF-8 inhibits the proliferation and differentiation of muscle precursor cells (muscle satellite cells) by binding to receptors in these cells, thereby limiting muscle enlargement.
- **Natural control of muscle size**: GDF-8, as an inhibitor, can prevent abnormal muscle proliferation and maintain the normal physiological size and function of muscles.
2. The relationship between GDF-8 and muscle atrophy
In some disease states, the inhibition of GDF-8 can lead to muscle atrophy. For example, certain neuromuscular diseases, aging, and long-term inactivity can activate GDF-8 and lead to loss of muscle mass.
- **Regulation of muscle atrophy**: Overexpression of GDF-8 may lead to muscle atrophy. Therefore, researchers are also exploring the treatment of muscle atrophy symptoms by inhibiting the expression of GDF-8. For example, blocking the signaling pathway of GDF-8 may counteract the loss of muscle mass caused by aging or disease.
3. The relationship between GDF-8 and obesity and metabolism
Recent studies have shown that GDF-8 not only plays a role in muscle growth, but is also associated with fat metabolism and weight control. GDF-8 may have potential benefits in regulating energy balance, fat storage and metabolism.
- **Weight control**: Some studies have found that regulating the expression of GDF-8 may help reduce fat accumulation and promote fat metabolism. Intervention through the GDF-8 pathway may help treat obesity-related metabolic diseases.
- **Potential treatment for metabolic syndrome**: GDF-8 inhibition may improve insulin sensitivity, reduce blood sugar and blood lipid levels, and has certain therapeutic potential for diseases such as metabolic syndrome.
4. The relationship between GDF-8 and aging
Muscle atrophy (sarcopenia) during aging is at the core of many health problems in the elderly. With age, GDF-8 levels may gradually increase, leading to a gradual loss of muscle mass. Therefore, regulating the expression of GDF-8 has become an important direction for the study of aging-related diseases.
- **Anti-aging effect**: Some studies have shown that GDF-8 inhibition can delay the aging process, enhance muscle growth and regeneration, and improve muscle function. In particular, GDF-8 inhibitors may have potential application prospects in delaying age-related muscle atrophy.
5. The relationship between GDF-8 and cardiovascular health
The effects of GDF-8 are not limited to skeletal muscle, but may also affect heart health. The heart is composed of special muscle cells, so GDF-8 may play an important role in heart development and repair.
- **Myocardial repair and regeneration**: Some studies have shown that GDF-8 may play a role in the repair process after myocardial injury. Inhibiting the expression of GDF-8 may promote the regeneration of myocardial cells and help restore heart function.
- **Therapeutic potential for heart disease**: By controlling the signaling pathway of GDF-8, it may help treat diseases associated with impaired heart function, such as heart failure.
6. The relationship between GDF-8 and cancer
The relationship between GDF-8 and cancer is relatively complex. Studies have shown that GDF-8 may have a dual effect on the occurrence, development and metastasis of tumors. In some types of cancer, excessive expression of GDF-8 may help inhibit tumor growth; while in other types of cancer, it may promote the proliferation and metastasis of tumor cells.
- **Anti-tumor effect**: In some studies, overexpression of GDF-8 has been found to inhibit the proliferation of certain types of tumor cells and slow the development of tumors.
- **Tumor cell proliferation**: However, in some cases, GDF-8 may accelerate the progression of cancer by promoting the proliferation of certain cells. Therefore, the potential of GDF-8 in tumor treatment still needs further research and verification.
7. Potential applications of GDF-8
Based on the biological functions of GDF-8, scientists are exploring ways to regulate its expression directly or indirectly to achieve the goal of treating various health problems.
- **Treatment of muscle diseases**: By inhibiting the action of GDF-8, it is expected to treat muscle atrophy symptoms caused by overexpression of GDF-8.
- **Treatment of obesity and metabolic diseases**: Inhibition of GDF-8 may help reduce obesity and metabolic disorders and improve insulin sensitivity.
- **Development of anti-aging drugs**: Regulating the activity of GDF-8 may become a new direction for the development of anti-aging drugs, helping to delay muscle decline and improve the quality of life of the elderly.
8. Research progress of GDF-8 inhibitors
Currently, inhibitors targeting GDF-8 have entered the preclinical research stage. GDF-8 inhibitors may help enhance muscle growth, reduce muscle loss during aging, and promote skeletal muscle repair by targeting GDF-8 receptors or signaling pathways.
- **Preclinical studies**: Studies have shown that by using GDF-8 inhibitors, the muscle mass of elderly animals has been restored and their physical activity ability has also improved.
- **Potential drug development**: Scientists are developing GDF-8 inhibitors as a potential therapeutic drug, especially for muscle-related diseases and aging problems.
Summary
GDF-8 is a factor that plays an important role in muscle growth, aging, metabolism, etc. Although it is mainly characterized by inhibiting muscle growth, its regulatory role in some diseases and aging processes may bring significant health benefits. With the deepening of research, the potential application of GDF-8 in the treatment of various diseases has gradually emerged, including muscle atrophy, obesity, aging and metabolic diseases. In the future, GDF-8-related therapeutic strategies are expected to provide a new direction for medicine.

Contact Details(WhatsApp Telegram ) And Payment Methods
WhatsApp/Telegram:+852 6749 2648
Gmail:lucasraws207@gmail.com
Skype:live:.cid.8f21dc7fc6621ba7

FAQ
Q: What are GDF-8 drugs?
A: GDF-8 drugs refer to drugs that treat related diseases by regulating or inhibiting the GDF-8 signaling pathway. GDF-8 usually plays a role in limiting muscle growth under normal circumstances. Therefore, GDF-8 inhibitors are expected to be used to treat diseases such as muscular dystrophy, muscle weakness, and sarcopenia. By inhibiting GDF-8, muscle growth and repair can be enhanced, improving the patient's muscle health.
Q: What is the role of GDF-8 in muscle?
A: GDF-8 is a natural inhibitor of muscle development, which mainly inhibits muscle cell proliferation and differentiation by binding to receptors in muscle cells. Under normal circumstances, GDF-8 limits excessive muscle growth, but in certain situations (such as disease or aging), its excessive levels can lead to a decrease in muscle mass. Therefore, GDF-8 is considered a potential target for muscle atrophy or wasting diseases.
Q: How do GDF-8 inhibitors help treat muscular dystrophy?
A: Muscular dystrophy (such as Duchenne muscular dystrophy, sarcopenia, etc.) is usually accompanied by a gradual loss of muscle mass and strength. In these diseases, GDF-8 expression may be elevated, resulting in limited muscle cell growth. GDF-8 inhibitors can promote muscle regeneration and growth by inhibiting the function of this factor, thereby slowing or reversing muscle atrophy. Studies have shown that GDF-8 inhibitors may improve muscle health by activating muscle stem cells and enhancing muscle synthesis and repair capabilities.
Q: How is the clinical research progress of GDF-8 inhibitors?
A: Currently, multiple GDF-8 inhibitors are undergoing clinical trials to evaluate their effectiveness in treating muscle diseases. For example, **Myostatin inhibitors** (Myostatin is another name for GDF-8) have shown the potential to promote muscle growth in animal experiments and have shown certain therapeutic effects in some early clinical studies. Drugs such as **ACE-083** and **MYO-029** have been developed and used in clinical trials to explore their use in treating diseases such as muscular dystrophy.
Hot Tags: peptides gdf-8 1mg cas:60580-62-7, China peptides gdf-8 1mg cas:60580-62-7 manufacturers, suppliers, factory, PT141 Improve training passion and endurance, GDF-8, Follistatin 344 and Fst 344, ACE 031 CAS 1621169 52 5, Follistatin 344 Enhance the vitality and growth rate of muscle cells, MGF Promote muscle repair and accelerate fat burning

